RxDoctor Payments Data

Jenifer Hadley, DO

Family Medicine · Charleston, WVNPI 1528038668

Payments from drug & device makers

$230in general payments, 2019–2025

Across 15 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$56
  • Merck$44
  • Amgen$41
  • AstraZeneca$27
  • Corcept Therapeutics$19
  • Shire North American Group Inc$16
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$21694%
  • Education$146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$230 in reported general payments places this provider in the 40th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$34,119
Medicare patients
202
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$91,299
OzempicSemaglutide56$71,991
JardianceEmpagliflozin53$65,859
MounjaroTirzepatide36$55,781
JanuviaSitagliptin Phosphate29$30,613
XareltoRivaroxaban28$27,709
EntrestoSacubitril/Valsartan22$19,407
Breo ElliptaFluticasone/Vilanterol14$10,238
MyrbetriqMirabegron13$10,076
SymbicortBudesonide/Formoterol Fumarate25$8,839
Spiriva HandihalerTiotropium Bromide11$8,440
Tresiba Flextouch U-100Insulin Degludec12$6,738
VascepaIcosapent Ethyl14$6,023
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$4,866
Levothyroxine Sodium281$4,796

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$13$92,66689 claims
MerckJanuvia$44$30,61329 claims
AstraZenecaSymbicort$27$8,83925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →